The biochemical basis of Parkinson's disease: The role of catecholamineo-quinones: A review-discussion
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
This paper reviews the possible role of catecholamineo-quinones (OQs) in the genesis of Parkinson's disease (PD). This disease is characterized by damage caused to the pigmented catecholaminergic cells in various areas of the brain. The pigment involved is neuromelanin that is the end product of catecholamine oxidation by theo-quinone route. Evidence is presented regarding the overproduction in PD of these catecholamine OQs that damage the electron chain in the mitochondria leading to cell death. The roles of glutathione S-transferase and reactive oxygen species in this are also surveyed. A review of all known biochemical properties of theseo-quinones is included. The hypothesis is put forward that an important factor in the genesis of PD may be the overload by environmental toxins of enzymes such as glutathioneS-transferase that also detoxify catecholamine OQs.
- Baez, S., Segura-Aguilar, J., Widersten, M., Johansson, A.S. and Mannervik, B. (1997) “Glutathione transferases catalyze the detoxification of oxidized metabolites (OQs) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes”Biochem. J. 324, 25–28.
- Barzilai, A., Zilkha-Falb, R., Daily, D., Stern, N., Offen, D., Ziv, I., Melamed, E. and Shirvan, A. (2000) “The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity.”,J. Neural. Trans. Supp.,60, 59–76.
- Basma, A.N., Morris, E.J., Nicklas, W.J. and Geller, H.M. (1995) “l-DOPA cytotoxicity to PC12 cells in culture is via its autooxidation”,J. Neurochem. 64, 825–832.
- Ben-Schachar, D., Zuk, R. and Glinka, Y. (1995) “Dopamine neurotoxicity: inhibition of mitochondrial respiraton”,J. Neurochem. 64, 718–723.
- Berman, S.D. and Hastings, T.G. (1997) “Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species”,J. Neurochem. 69, 1185–1195.
- Berman, S.D. and Hastings, T.G. (1999) “Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease”,J. Neurochem. 73, 1127–1137. CrossRef
- Cassarino, D.S., Parks, J.K., Parker, W.D.J. and Bennett, Jr, J.P. (1999) “The parkinsonian neurotoxin MPP+ opens the mitochondrial pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism”,Biochem. Biophys. Acta 1453, 49–62.
- De Iuliis, A., Burlina, A.P., Zanatta, L., Boschetto, R., Zambenedetti, P. and Galzigna, L. (2002) “Increased dopamine peroxidation in post-mortem Parkinsonian brains,” Submitted for publication.
- Drukarch, B., Langeveld, C.H. and Stoof, J.C. (1999) “Glutathione homeostasis linked to the vesicular storage of dopamine in rat PC12 pheochromocytoma cells”,Exp. Neurol. 145, S39.
- Fornstedt, B., Brun, A., Rosengren, E. and Carlsson, A. (1989) “The apparent autooxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra”,J. Neural. Transm. 1, 279–295. CrossRef
- Gai, W.P., Geffen, L.B., Denoroy, L. and Blessing, W.W. (1993) Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease,Ann. Neurol. 33, 357–367. CrossRef
- Galzigna, L., Schiappelli, M.P., Rigo, A. and Scarpa, M. (1999) “A rat brain fraction and different purified peroxidases catalyzing the formation of dopaminochrome from dopamine”,Biochem. Biophys. Acta 1427, 329–336.
- Galzigna, L., De Iuliis, A. and Zanatta, L. (2000) “Enzymatic dopamine peroxidation in substantia nigra of human brain”,Clin. Chim. Acta 300, 131–138. CrossRef
- Hastings, T.G. (1995) “Enzymatic oxidation of dopamine: the role of prostaglandin H synthase”,J. Neurochem. 64, 919–924.
- Jenner, P. and Olanow, C.W. (1998) “Understanding cell death in Parkinson's disease”,Ann. Neurol. 44(S1), S77-S84.
- Jenner, P., Dexter, D.T., Sian, J., Schapira, A.H.V. and Marsden, C. (1992) “Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease”,Ann. Neurol. 32, S82-S88. CrossRef
- Jimenez del Rio, M., Pardo, C.V., Pinxteren, J., de Potter, W., Ebinger, G. and Vauquelin, G. (1994) “Interaction of serotonin-and dopamine-related neurotoxins with “serotonin binding proteins” in bovine frontal cortex”,Biochem. Pharmacol. 48, 253–258.
- Kawamata, H., McLean, P.J., Sharma, N. and Hyman, B.T. (2001) “Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations”,J. Neurochem. 77, 929–934. CrossRef
- Klegeris, A., Korkina, L.G. and Greenfield, S.A. (1995) “A possible interaction between acetylcholinesterase and dopamine molecules during oxidation of the amine”.Free Rad. Biol. Med. 18, 223–230. CrossRef
- Kuhn, D.M. and Arthur, Jr, R. (1988) “Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons”,J. Neurosci. 18, 7111–7117.
- Lancelot, E., Callebert, J., Plotkine, M. and Boulu, R.G. (1995) “Striatal dopamine participates in glutamate-induced hydroxyl radical generation”,NeuroReport 6, 1033–1036. CrossRef
- Lereugle, B., Faucheux, B.A., Bouras, C., Nillesse, N., Spik, G., Hirsch, E.C., Agid, Y. and Hof, P.R. (1996) “Cellular distribution of iron-binding protein lactotransferrin in the mesencephlon of Parkinson's disease cases”,Arch. Neuropathol. 91, 566–572. CrossRef
- Luo, T., Hattori, A., Munoz, J., Qin, Z.-H. and Roth, G.S. (1995) “Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-κB in rats”,Mol. Pharmacol. 56, 254–264.
- Marstein, S., Jellum, E., Nesbakken, R. and Perry, T.L. (1981) “Biochemical investigations of biopsied brain tissue and autopsied organs from patients with pyroglutamic acidemia (5-oxoprolinemia)”,Clin. Chim. Acta 111, 219–222. CrossRef
- Mattammal, M.B., Strong, R., Lakshuri, V.M., Chung, H.D. and Stephenson, A.H. (1995) “Prostaglandin H synthetase-mediated metabolism of dopamine; implication for Parkinson's disease”,J. Neurochem. 64, 1645–1654. CrossRef
- McGuire, S.O., Ling, Z.D., Lipton, J.W., Sortwell, C.E., Collier, T.J. and Carvey, P.M. (2001) “Tumor necrosis factor alpha is toxic to embryonic mesencephalic neurons”,Exp. Neurol. 169, 219–230. CrossRef
- McLaughlin, B.A., Nelson, D., Erecinska, M. and Chesselet, M.-F. (1998) “Toxicity of dopamine to striatal neuronsin vitro and potentiation of cell death by a mitochondrial inhibition”,J. Neurochem. 70, 2406–2411. CrossRef
- Merad-Boudia, M., Nicole, A., Santiard-Baron, D., Saillé, C. and Ceballos-Picot, I. (1998) “Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease”,Biochem. Pharmacol. 56, 645–655. CrossRef
- Mirza, B., Hadberg, H., Thomsen, P. and Moos, T. (2000) The absence of reactive astiocytosis is indicative of a unique inflammatory process in Parkinson's disease.Neuroscience 95, 425–439. CrossRef
- Nakamura, K., Wang, W. and Kang, W.J. (1997) “The role of glutathione in dopaminergic neuronal survival”,J. Neurochem. 69, 1850–1858. CrossRef
- Rowe, D.B., Le, U., Smith, R.G. and Appel, S.H. (1998) “Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation”,J. Neurosci. Res. 53, 551–558. CrossRef
- Schapira, A.H.V., Mann, V.M., Cooper, J.M., Krige, D., Jenner, P.J. and Marsden, C.D. (1992) “Mitochondrial function in Parkinson's disease”,Ann. Neurol. 32, S116-S124. CrossRef
- Schmidt, J., Mertz, K. and Morgan, J.I. (1999) “Regulation of heme oxygenase-1 expression by dopamine in cultures C6 glioma and primary astrocytes”,Mol. Brain Res. 73, 50–59. CrossRef
- Segura-Aguilar, J. (1996) “Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome”,Biochem. Mol. Med. 58, 122–129. CrossRef
- Shen, X.-M. and Dryhurst, G. (1996) “Oxidation chemistry of (−)-norepinephrine in the presence ofl-cysteine”,J. Med. Chem. 39, 2018–2029. CrossRef
- Shen, X.-M., Xia, B., Wrona, M.Z. and Dryhurst, G. (1996) “Synthesis, redox properties,in vivo formation, and neurobehavioral effects ofN-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease”,Chem. Res. Toxicol. 9, 1117–1126. CrossRef
- Skellerud, K., Marstein, S., Schrader, H., Brundelet, P.J. and Jellum, E. (1980) “The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinemia)”,Acta Neuropath. 52, 219–225.
- Smythies, J. The Dynamic Neuron. Cambridge, MA. MIT Press (2002).
- Spencer, J.P.E., Jenner, P., Daniel, S.E., Lees, A.J., Marsden, D.C. and Halliwell, B. (1998) “Conjugates of catecholamines with cysteine and GSH in Parkinson's disease; possible mechanisms of formation involving reactive oxygen species”,J. Neurochem. 71, 2112–2122.
- Terland, O., Flatmark, T., Tangeras, A. and Grønberg, M. (1997) “Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species”,J. Mol. Cell. Cardiol. 29, 1731–1738. CrossRef
- Tief, K., Hahne, M., Schmidt, A. and Beerman, F. (1996) “Tyrosinase, the key enzyme in melanin synthesis, is expressed in murine brain”,Eur. J. Biochem. 241, 12–16. CrossRef
- Watts, P.M., Riedl, A.G., Douek, D.C., Edwards, R.J., Boobis, A.R., Jenner, P. and Marsden, C.D. (1998) “Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase”,Neuroscience 86, 511–519. CrossRef
- Xu, Y., Stokes, A.H., Roskoski, Jr, R. and Vrana, K.E. (1998) “Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase”,J. Neurosci. Res. 54, 691–697. CrossRef
- Zhang, F. and Dryhurst, G. (1994) “Effects ofl-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potentiarelevance to idopathic Parkinson's disease”,J. Med. Chem. 37, 1084–1098. CrossRef
- Zhang, J., Price, J.O., Graham, D.G. and Montini, T.J. (1998) “Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures”,Biochem. Biophys. Res. Comm. 248, 812–816. CrossRef
- The biochemical basis of Parkinson's disease: The role of catecholamineo-quinones: A review-discussion
Volume 4, Issue 1 , pp 77-81
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Parkinson's disease
- Reactive oxygen species
- Industry Sectors
- Author Affiliations
- 1. Center for Brain and Cognition, Department of Psychology, University of California, San Diego, 92093-0109, La Jolla, CA, USA
- 2. Department of Neuropsychiatry, Institute of Neurology, Queen Square, London, UK
- 3. Department of Diagnostics, Medical School, University of Padova, Padova, Italy